Nursing management of patients with malignant melanoma receiving adjuvant alpha interferon-2b

As the incidence of melanoma continues to increase, oncology nurses will be caring for more patients receiving adjuvant alpha interferon-2b. Managing the side effects from this therapy requires expert nursing care. The nurse's role throughout the year-long therapy is critical to ensure the patient's continued adherence to the treatment schedule.